The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Martin Wabitsch MD, PhD is Professor of Pediatrics at the University of Ulm, Germany and is the Head of the Division of Pediatric Endocrinology and Diabetes at the Department of Pediatrics and Adolescents Medicine in Ulm’s University Hospital. His clinical research focus comprises the physiology of body weight regulation in children, genetic obesity and leptin deficiency in human. His experimental research focus is the biology of the human adipocyte.
Dr. Wabitsch has had his clinical and experimental training at the Universities in Berlin (Free University), Ulm, Baltimore (Johns Hopkins) and Nice (Sophia Antipolis). Within an ESPE research fellowship he performed studies on the growth hormone receptor at the Hagedorn Research Institute. At present he is a member of the ESPE Science Committee.
Research Group Leader of Lifecourse Epidemiology Group at Center for Clinical Research and Prevention, Copenhagen University Hospital System, Copenhagen, Denmark
Dr. Jennifer L. Baker is a Senior Researcher and leader of the group on lifecourse epidemiology at the Center for Clinical Research and Prevention, Copenhagen University Hospital system, in Denmark. Her research programme investigates how body size and growth during childhood in combination with other exposures across the lifecourse relate to disease. Dr. Baker’s work focuses on short and long-term effects of overweight and obesity in children. She and her group have shown that a higher body mass index in childhood increases the risk during adult life of numerous non-communicable diseases including nine types of cancer, cardiovascular disease and type 2 diabetes.
Dr. Baker has authored over 100 peer-reviewed publications and has served on several international expert scientific committees. Dr. Baker is the co-chair for the European Association for the Study of Obesity Childhood Obesity Task Force.
Professor and head at Center of Pediatric Research, Leipzig University Children’s Hospital, Leipzig, Germany
Antje Körner is a pediatric endocrinologist and appointed Professor of Pediatric Research (since 2010) heading the Pediatric Research Unit of the University Children’s Hospital (since 2007) and is a consultant in pediatric endocrinology >10 years of the University Children’s Hospital Leipzig, Germany.
Her research focuses on the origin, mechanisms and consequences of childhood obesity following a translational approach that combines cell biology, molecular biology, clinical, and genetic studies. Her research fields are:
· Pathogenesis of obesity and metabolic and cardiovascular comorbidities in children
· Adipocyte differentiation and adipose tissue development in children
· (Epi)Genetics of obesity and associated disease in children
· Endocrinology of growth & development
She is integrated in local and international research networks and collaborations. She is coordinating the Leipzig-Dresden Partner site SaxoChiLD for the new German Center of Child and Youth Health. She has published more than original 180 articles in peer-reviewed international scientific journals and has been awarded numerous national and international prizes, e.g. Research Award of the European Society of Paediatric Endocrinology (ESPE) 2020, International Journal of Obesity Outstanding New Faculty Award (2016). She has raised more than 7 Mio Euro peer reviewed research grants, including the European Commission, German Research Foundation (DFG) and the Else Kröner-Memorial foundation.
Associate Professor of Medicine (Endocrinology & Metabolism) & Pediatrics (Pediatric Endocrinology) at Yale University School of Medicine, Director of Weight Management and Obesity Prevention at Yale Stress Center, Co-Director of the Yale Center for Weight Management
Ania Jastreboff, MD, PhD, is an Associate Professor in Medicine (Endocrinology & Metabolism) and Pediatrics (Pediatric Endocrinology) at Yale University School of Medicine, Director of Weight Management and Obesity Prevention at the Yale Stress Center, and co-Director of the Yale Center for Weight Management.
After completing a combined Internal Medicine and Pediatrics residency program, Dr. Jastreboff completed both an adult and a pediatric Endocrinology fellowship at Yale. During her dual fellowship, she also completed a PhD in the neurobiology of obesity, becoming board certified in Obesity Medicine, Adult Endocrinology, and Pediatric Endocrinology.
Dr. Jastreboff is a clinically active physician-scientist nationally and internationally recognized for helping to develop the 2016 Clinical Practice Guidelines for The Comprehensive Care of Patients with Obesity (AACE/ACE), educating the next generation of Obesity Medicine physicians by teaching annually at the Harvard Blackburn Treating Obesity course, the Columbia/Cornell Obesity course, selected international courses, and conducting cutting-edge clinical translational obesity research. Her research includes both large, multi-center clinical outcomes trials using anti-obesity medication as well as neuroimaging studies (fMRI and PET) examining the neurobiology underlying obesity and the mechanisms of anti-obesity medications. Dr. Jastreboff's research is supported by NIH/NIDDK (K23, R01s), American Diabetes Association (ADA), and industry funded multi-center clinical trials. Nationally, she serves as the vice-Chair of the Clinical Care Committee of The Obesity Society (TOS) and has been selected to serve as a Director on the American Board of Obesity Medicine (ABOM). Clinically, Dr. Jastreboff specializes in sophisticated use of anti-obesity medication combinations to help patients reach their weight and health goals!